EQS-Adhoc: O3 Holding GmbH (KD Pharma Group) acquires food-grade oil business from dsm- firmenich financed through shareholder loan

Disclosure of an inside Information under Article 17 of Regulation (EU) No 5G6/2014

O3 Holding GmbH (KD Pharma Group) acquires food-grade oil business from dsm- firmenich financed through shareholder loan

BEXBACH, GERMANY – 31 December 2025 – Today, O3 Holding GmbH (the Company), the holding company of KD Pharma Group, through its subsidiary KD Swiss GmbH, signed agreements with dsm-firmenich to acquire the distribution and supply of the

food-grade oil business from dsm-firmenich. The acquisition will be financed through a shareholder loan.

Closing of the transaction is expected for today and not subject to any condition’s precedent.

ABOUT KD PHARMA GROUP

KD Pharma Group is a CDMO that creates health solutions in the pharmaceutical and nutraceutical space. It is also the worldwide leading producer Omega-3 fatty acids for the pharmaceutical and nutraceutical markets, formulation and encapsulation

services, with about 700 employees and a presence in Norway, Germany, Switzerland, Canada, Peru and the US. The KD Pharma Group employs state-of-the-art technology which is protected by numerous patents. Visit www.kdpharmagroup.com to learn more.

IMPORTANT INFORMATION

This release contains forward-looking statements. These statements are based on plans, estimates and projections currently available to KD Pharma Group. Forward- looking statements therefore speak only as of the date they are made. KD Pharma

Group assumes no obligation to update such statements in light of new information or future events. By their nature, forward-looking statements involve risks and

uncertainties. A variety of important factors could cause actual results to differ materially from those in forward-looking statements.

2253476  02-Jan-2026 CET/CEST